Zurueck zur Suche

Reporte zur Charge U031563

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 4 NM 3 OR 2 FL 1 AL 1

VAERS 2478132

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031563

mild
Staat
OR
Alter
1,0
Geschlecht
F
Eingang
12.10.2022
Impfdatum
13.09.2022
Beginn
20.09.2022
Tage bis Beginn
7,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia Rash Streptococcus test negative

Symptomtext

Pinpoint appearing rash on torso but not hands or feet. Mother reported subjective fever at home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
Rapid Strep A - Negative
Aktuelle Erkrankungen
Diarrhea 08/25/22
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2404519

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031563

mild
Staat
TX
Alter
9,0
Geschlecht
F
Eingang
08.08.2022
Impfdatum
01.08.2022
Beginn
01.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site reaction Urticaria

Symptomtext

Child developed welt and redness on and around injection site

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NO
Allergien
NO
Vorherige Impfungen
-

VAERS 2339235

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031563

mild
Staat
TX
Alter
4,0
Geschlecht
M
Eingang
28.06.2022
Impfdatum
14.06.2022
Beginn
24.06.2022
Tage bis Beginn
10,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fluid retention Rash Rash papular

Symptomtext

Began with scattered papular rash to upper back and chest, spreading down to trunk, some were fluid filled

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
No
Vorgeschichte
None
Andere Medikamente
Multivitamins
Allergien
None
Vorherige Impfungen
-

VAERS 2296597

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031563

mild
Staat
NM
Alter
4,0
Geschlecht
M
Eingang
26.05.2022
Impfdatum
24.05.2022
Beginn
25.05.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

Findings on clinical exam appear to be a zoster like rash. This is certainly possible in the setting of varicella vaccine and a varicella reaction. The chances of this occurring are in the order of 4-8 and 10,000. In my review it appears that no treatment is necessary. His symptoms are fairly mild and this should resolve on its own. We did discuss the importance of covering this and monitoring for signs of secondary infection with bacteria. He is also contagious, mildly so in contact with patient's that have not had chickenpox or are immunocompromised should be limited.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Acute sinusitis, allergic rhinitis, respiratory tract congestion and cough
Vorgeschichte
N/A
Andere Medikamente
Albuterol sulfate inhaler, Flonase, claritin, Montelukt - medications are as needed
Allergien
Amoxicillin
Vorherige Impfungen
-

VAERS 2194561

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031563

mild
Staat
TX
Alter
4,0
Geschlecht
F
Eingang
23.03.2022
Impfdatum
21.03.2022
Beginn
21.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site swelling Injection site vesicles

Symptomtext

3/21/22 AREA OF INJECTION SWOLLEN 3/23/22 INJECTION AREA BLISTERED UP

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
N/A
Allergien
-
Vorherige Impfungen
-

VAERS 2675823

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031563

gering
Staat
NM
Alter
-
Geschlecht
U
Eingang
23.08.2023
Impfdatum
09.08.2023
Beginn
09.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

HCP reports that the patient has not experienced any symptoms.; HCP called to report that an expired dose of PROQUAD was given to a patient today 8/9/2023. Expiration date of PROQUAD 4/6/2023. HCP reports no previous TEs reported on product. HCP reports that the patient has not experienced any symptoms. HCP gave; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions or medical history provided. Concomitant medication included sterile diluent. On 09-AUG-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, 0.5 milliliter, lot #U031563 was valid, expiration date established as 06-APR-2023, therapy type rHA for prophylaxis (expired product administered). The reporter stated that the patient had not experienced any symptoms (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2668712

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031563

gering
Staat
NM
Alter
4,0
Geschlecht
M
Eingang
09.08.2023
Impfdatum
09.08.2023
Beginn
09.08.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Poor quality product administered

Symptomtext

An expired dose of MMRV (Proquad) administered to patient. Dose expired 4/6/23. Contacted CDC and Merck for guidance. Per CDC and Merck, no expectation of patient harm. Dose potency potentially diminished. Consider additional booster at least 4 weeks after administration date. Log dose as invalid. Administering medical professional attempting to contact patient parent to advise and schedule appointment to reimmunize with additional booster of MMRV after 4 weeks.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
None as of today.
Aktuelle Erkrankungen
Acute respiratory failure from viral pneumonia 7/4/23
Vorgeschichte
None known
Andere Medikamente
None
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2627921

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031563

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
08.05.2023
Impfdatum
19.04.2023
Beginn
19.04.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs; Caller reported expired dose of PROQUAD was administered. No other information provided. No additional AEs or PQC reported.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. Information regarding the patient's medical history, concurrent conditions, and past drug allergies or drug reactions were not provided. Concomitant medication included sterile diluent (0.7 milliliter (mL), lot # W025272, expiration date reported and stablished as 04-OCT-2023). On 19-APR-2023, the patient was vaccinated with an expire dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) subcutaneous injection 0.5 mL, subcutaneously (lot #U031563 confirmed to be a valid lot number with an expiration date reported and stablished as 06-APR-2023) administered as prophylaxis (strength and anatomical location were not provided) (expired product administered). No additional adverse event (AE's) was reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2342490

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U031563

gering
Staat
OR
Alter
1,0
Geschlecht
M
Eingang
29.06.2022
Impfdatum
29.06.2022
Beginn
29.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

MMR and Varicella Vaccine ordered today. MA gave MMRV and Varicella vaccine. Patient received double dose of varicella. Error was discovered after patient left clinic. CDC Vaccine Information Line contacted to discuss/learn of any possible complications of which none where identified. Contacted mom to inform of error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
None
Allergien
Milk Protein Sensitivity
Vorherige Impfungen
-

VAERS 2335482

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031563

gering
Staat
FL
Alter
0,2
Geschlecht
U
Eingang
27.06.2022
Impfdatum
26.05.2022
Beginn
26.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No additional AE reported; a 2 month old infant was inadvertently administered a dose of PROQUAD; This spontaneous report was received from a physician, referring to a 2 months old patient. The patient's medical history and concurrent condition were not provided. Concomitant medication included sterile diluent. On 26-MAY-2022, the patient was inadvertently vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # U031563, expiration date 06-APR-2023; strength, dose number and route were not reported) at dose of 0.5 milliliter for prophylaxis (product administered to patient of inappropriate age). No additional adverse event (AE) reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2329442

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031563

gering
Staat
AL
Alter
4,0
Geschlecht
M
Eingang
23.06.2022
Impfdatum
23.05.2022
Beginn
23.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Wrong product administered

Symptomtext

4 year old in clinic for preschool immunizations. Due Kinrix and Proquad. Nurse inadvertently administered Pentacel and Proquad. Child experienced no adverse reactions. Nursing Director instructed clinic to complete VAERS report due to wrong vaccine being given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None Known
Allergien
NKDA
Vorherige Impfungen
-